Friday, March 29, 2019

The Rise of #CBD Products in Health and Wellness: (NASDAQ: $VFF) (OTC: $HIPH) (OTCQB: $SOLCF) (CSE: $LOVE.C)


The Rise of #CBD Products in Health and Wellness: (NASDAQ: $VFF) (OTC: $HIPH) (OTCQB: $SOLCF) (CSE: $LOVE.C)

Point Roberts, WA and Delta, BC - March 29, 2019 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot focusing on the rise of CBD within the overall cannabis market in the US and internationally, and how companies are preparing to deal with this explosive market.

With the passing of the 2018 Farm Bill in the US, CBD represents a developing sector with many vendors now seeking national reach to US customers. The rise in popularity for CBD products is driven by consumers seeking natural-based health & wellness solutions to treat various ailments; from inflammation, to anxiety and insomnia amongst many others. As a result, the hemp-derived CBD market has been estimated to reach US $22 billion by 2022.


One of the larger companies in the CBD space, Village Farms International, Inc. (TSX: VFF) (NASDAQ: VFF) recently applauded the actions of the Texas Department of Health and Human Services in de-scheduling hemp, including its cannabinoids (except for delta-9 tetrahydrocannabinol (THC) in compliance with the 2018 Farm Act and Texas law.  Under Texas law, the removal of hemp from the controlled substances schedule will be effective on April 5, 2019, 21 days after the schedule's publication. Texas still must pass a hemp bill to enable the creation of a State Hemp Plan under the 2018 Farm Act and develop a thoughtful regulatory regime to support the hemp industry and protect consumers.

With more CBD markets opening up, American Premium Water Corporation (OTC: HIPH), a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors, recently announced that it has engaged A&R Opportunity to manage and fund a national sales team based out of Northeast Ohio that will help market and sell the Company’s products nationwide. The arrangement was necessitated by overwhelming demand for the Company’s products, including its LALPINA CBD beverage and CBD topical products from its most recent acquisition of plant + body essentials.  
         
CEO of American Premium Water Corporation, Ryan Fishoff commented, “I am pleased to announce we have engaged with A&R to help oversee the Company’s national sales strategy. The inbound demand has been overwhelmingly strong and it became apparent over the past few weeks that the Company needed more assistance in managing and servicing sales accounts. Their location in Northeast Ohio also provides us with a presence in the Midwest, an area that we have not been focusing on, but over the past few months became clear to the Company was an area that needed to be addressed with burgeoning demand for CBD products. The terms of the agreement were also very favorable to the Company, as it is performance based, so all party’s incentives are aligned. This will be beneficial for the Company going forward as we look to continue to expand our distribution footprint nationwide and rollout new products in the coming months.” 

The non-alcoholic beverage marketplace is estimated to generate revenue of approximately USD$1.2 trillion by 2023, according to Markets and Research analysis. Companies employing innovative marketing strategies, more flavor choices, and the use of natural, high-quality ingredients will continue to drive market growth in the category.

This may explain why SOL Global Investments Corp. (CSE: SOL) (OTCQB: SOLCF) just announced its investment in leading premium soda-maker Jones Soda Co.

SOL Global's total investment represents approximately 8.19% of the total issued and outstanding common shares of Jones Soda which, based on publicly available information, makes it the company's largest stockholder. SOL Global has filed a Schedule 13D with the United States Securities and Exchange Commission describing its investment in Jones Soda.

Cannara Biotech Inc. (CSE: LOVE) is also looking into marketing and distribution for CBD, having recently announced that its subsidiary, Global shopCBD.com Inc. has closed private rounds of financing for aggregate proceeds of $8,865,849.15. 

From the news: "As the hemp CBD consumer markets continue to evolve, what is increasingly clear is the health and wellness segment is becoming more prominent," said Zohar Krivorot, President and CEO of Global shopCBD.com. "The high level of investor interest in participating in shopCBD.com underscores the potential of both CBD products overall and moreover, a best-in-class online platform to serve this market." 

There can be no doubt that the CBD sector is about to take off as consumers wait impatiently for products to become available, but is the industry properly prepared? As we saw with recreational cannabis in Canada, many companies are likely to be unprepared to keep up with supply, but there are numerous companies like the ones above heeding the warning signs and taking the proper preemptive actions to ensure they are ready when the CBD flood gates open.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Follow us on Cannabis Social Media

Disclaimer:  Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this article HIPH  is a paid for service  on Investorideas.com – third party., Learn more about costs and our services https://www.investorideas.com/News-Upload/. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Contact Investorideas.com
800-665-0411


#CBD Companies Making Moves for Warmer Weather in Mexico and South America; (CSE: $CNNA.C) (TSX: $KHRN.TO) (CSE: $SOL.C) (CSE: $CANA.C)


#CBD Companies Making Moves for Warmer Weather in Mexico and South America; (CSE: $CNNA.C) (TSX: $KHRN.TO) (CSE: $SOL.C) (CSE: $CANA.C)

Point Roberts, WA and Delta, BC - March 29, 2019 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at how, as CBD gains momentum in the US, companies are eyeing the next potential markets; mainly south of the border in Mexico and South America.

In November 2018, Mexico announced approval for the importation and sale of cannabis products at pharmacies and retailers across the country to service the Mexican population of 130+ million.  Sixty product licenses have been initially approved by the COFEPRIS thus far, and it is expected this decision will make cannabis products like hemp-derived CBD available on the shelves of general retailers across the nation.

CannaOne Technologies (CSE: CNNA), a company that develops and markets various digital tools to service various segments for the cannabis industry in Canada, with its flagship product BloomKit, is taking advantage of this new southern market potential. The company recently announced entering into a formal agreement with Manna Health Services SA de CV of Mexico City, to undertake the development, launch, and operation of an industry-leading, online CBD product purchase and delivery marketplace for the Country of Mexico. The agreement was signed on March 5, 2019, with a contract term of 36 months and an option to renew for an additional 60 months at the conclusion of the initial period.



"BloomKit, our enterprise software solution, will give Manna the capability to offer a flagship and fully operational online CBD marketplace once Mexican regulations are finalized. For example, it will offer Manna the ability to inherently monitor and track pick-up and delivery logistics, and the capability to deliver historical and current trending analytics to ensure optimal management of all CBD sales channels. It will provide this all with the benefit of a simple and easy to use built-in eCommerce solution."

Currently, Manna Health is approved by the Mexican government to buy, sell, lease, distribute, import, or export any products related to health and wellness. Once this CBD marketplace has launched, Manna has further committed to CannaOne to jointly study, analyze and utilize all market and consumer data that is collected and retained through the marketplace."

CANNAMERICA BRANDS CORP. (CSE: CANA) (OTCQB: CNNXF) is also looking into Mexico for CBD, having announced that it has entered into a binding letter of intent to create a joint venture with Sericea Labs S.A. de C.V. and CBDistribution Company Ltd., with the intention of building a facility in Mexico for importing and warehousing licensed CBD products as well as CBD oils and tinctures destined for refining.

When and if permitted under Mexican laws, the Company, SERICEA and CBDC also plan on acquiring, importing and cultivating industrial hemp biomass for extraction into CBD isolate to be used for multiple product lines which utilize CBD. Subject to Board approval from the Company and completion of satisfactory due diligence, the JV Parties intend to enter into a definitive joint venture agreement on or before April 30, 2019.

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF), a vertically integrated cannabis leader is focused not only on Mexico, but all of Latin America, having recently announced participating in Cosmoprof Worldwide Bologna, which took place March 14-17 in Bologna, Italy.

Kuida®, the first consumer brand for Khiron's wellness unit, brings the benefits of cannabidiol (CBD) to a comprehensive portfolio of skin and body care products for women. Launched in Colombia in October 2018 through retail, wholesale and online channels, Kuida® will now target the global skincare market which, according to Euromonitor International is expected to reach US$131 Billion in 2019.

SOL Global Investments Corp. (CSE: SOL) (OTCQB: SOLCF) also put a focus on international CBD in February, when the company announced the formation of a new international hemp-focused subsidiary, Heavenly Rx Ltd.

From the news:
"We are launching Heavenly Rx with the aim of acquiring a portfolio of battle-tested and proven hemp/CBD companies while also acquiring certain unique brands for which we believe CBD and hemp-infused products could drastically change their growth," added SOL's chief investment officer Andy DeFrancesco. "We are more bullish than ever about the future of the hemp and CBD industries globally, and Heavenly Rx will without a doubt be the vertically integrated leader in the space. Heavenly Rx is not simply an investment company, but rather a laser-focused global Hemp and CBD company only for all operations under the Heavenly Rx banner."

CBD is already on the tip of everyone’s tongue in the US at the moment and it seems this “hype” is extending outward into the Latin American community and Europe. The import/export of US CBD is expected to take off in 2019, and companies looking South and East could gain a sizeable advantage due to the massive consumer populations available.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks
 
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Follow us on Cannabis Social Media

Disclaimer/Disclosure:. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this article featuring CannaOne Technologies Inc. (CNNA.CN) is a paid for service on Investorideas.com – third party. Learn more about costs and our services https://www.investorideas.com/News-Upload/
Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Contact Investorideas.com
800-665-0411


Thursday, March 28, 2019

Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Aphria (TSX: $APHA.TO) (NYSE: $APHA), Choom (CSE: $CHOO.C) , Aurora (TSX: $ACB.TO) (NYSE: $ACB), FSD Pharma (CSE: $HUGE.C), Khiron (TSXV: $KHRN.V), Green Growth (CSE: $GGB.C) and Nextleaf (CSE: $OILS.C)


Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Aphria (TSX: $APHA.TO) (NYSE: $APHA), Choom (CSE: $CHOO.C) , Aurora (TSX: $ACB.TO) (NYSE: $ACB), FSD Pharma (CSE: $HUGE.C), Khiron (TSXV: $KHRN.V), Green Growth (CSE: $GGB.C) and Nextleaf (CSE: $OILS.C)



Delta, Kelowna, BC –March 28, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today’s podcast overview/transcript:

Good afternoon and welcome to another Investorideas.com “potcast”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we are looking at announcements from Aphria Inc. (TSX: APHA) (NYSE: APHA), Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF), Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB), FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF), Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF), Green Growth Brands, Inc. (CSE: GGB) (OTCQB: GGBXF) and Nextleaf Solutions Ltd. (CSE: OILS).

Aphria Inc.  announced that it will release financial results for the fiscal third quarter and nine months ended February 28, 2019 on April 15, 2019 before market open.

Choom Holdings Inc., an emerging adult and medical use cannabis company that has secured one of the largest national retail networks in Canada, announced that it has signed a memorandum of understanding with Better Choice Company, Inc. for the exclusive Canadian distribution rights to Better Choice's CBD Bona Vida brand of products targeted for animal health and wellness once approved for sale in Canada. The terms of the MOU are not material.

According to the American Pet Products Association, U.S. pet owners are estimated to have spent over $70 billion in 2018 on pet supplies, treatments and veterinary care.  As CBD pet products become more readily available and accepted, well positioned suppliers and distributors will be able to exploit the tremendous opportunities for growth in the CBD pet sales.

Under its Bona Vida brand, Better Choice offers a suite of CBD pet focused products in the form of oils and soft chews with several formulations designed to aid the state of good health and well-being in pets.  Bona Vida has formulations which specifically target animals Relaxation & Heart Support, Muscle & Joint, as well as, Skin & Body.

"We are excited that Better Choice has chosen us as their exclusive distributor in Canada for their pet focused CBD products," states Chris Bogart, President and CEO of Choom. "We recognize the importance of growing our brand portfolio and having the sole distribution rights for Better Choice products helps us achieve that in an entirely new market on the horizon in pet use products.  From what we know of in the United States, the CBD products for pet use market has proven to be a high margin business. As the normalization of cannabis-based products in Canada grows, consumers will begin to shift towards these new natural alternative treatments for their pets."

Aurora Cannabis Inc. announced today that the Company and its wholly-owned subsidiary CanniMed Therapeutics, have added product information numbers (PINs) to 78 medical cannabis products to better facilitate and track insurance coverage for their Canadian patients. The products that received PINs include dried flower, capsules, soft gels, topicals and oils.

PINs help employers and insurance companies classify and incorporate health care products into benefit coverage plans. Patients submitting claims to their third-party insurer can now identify specific products and thereby speed up the adjudication and medical coverage process.  MedReleaf, another wholly-owned subsidiary of Aurora, introduced PINs to 57 medical cannabis products in 2018.

"This is great news for insurance companies, employers and most importantly our patients," said Aurora CEO Terry Booth. "Introducing PINs for medical cannabis products will make the claims process more seamless, enabling insurance companies to add these products to their formularies while providing patients and employers with a simplified process to complete claims. It's another step toward enhancing patient access, something Aurora cares deeply about."

FSD Pharma Inc. announced today the signing of a consulting agreement with Joseph L. Romano, a well-respected lawyer with a strong track-record in personal injury law. Mr. Romano has been working with medical cannabis since 2006, assisting people coping with chronic pain to have access to medical cannabis, a viable alternative to opioid based medications.
Pursuant to the terms of the agreement, Mr. Romano will provide consulting on the inner workings of third party actions, WSIB claim handling, first party coverage and no fault benefits across Canada. Mr. Romano will also assist in identifying strategic acquisitions that will enhance shareholder value.

Commenting on the agreement, Dr. Raza Bokhari, Executive Co-Chairman and interim CEO said, "We are very excited to engage Mr. Romano in advance of our anticipated sales license. This is a very timely and important agreement for FSD Pharma to maximize the opportunities in the Canadian market for our products and fits well with our strategy of establishing the company as a leader in medical cannabis."

Khiron Life Sciences Corp., a vertically integrated cannabis leader with core operations in Latin America, announced today its participation, through Matt Murphy's appointment, in the newly formed National Cannabis Roundtable ("NCR"), a campaign aimed at reforming US federal cannabis laws. The NCR will focus on advocating for a rational legal framework for cannabis reform in the US with former Speaker of the House, John Boehner, serving as Honorary Chairman.

Matt Murphy, Khiron Vice President of Compliance, who will represent the Company on the NCR, stated, "With two-thirds of Americans indicating support for legalization of cannabis in some form, and safety and security being central to our mission across the entire supply chain, we believe that now is the time to work alongside our colleagues to inform and advocate for an open market that improves lives, creates jobs and establishes a national cannabis industry for the 21st century."
         
As Vice President of Compliance for Khiron and former Chief of Pharmaceutical Investigations for the U.S. Drug Enforcement Administration ("DEA"), Mr. Murphy is an executive leader with broad based domestic and international expertise in both the federal and private sectors. As a career Special Agent with the DEA for 25 years, he served in a multitude of positions in the fields of drug law enforcement, risk assessment and system development, regulatory compliance, and training. Mr. Murphy directs the Company's compliance activity by implementing closed loop systems to prevent product diversion and to enhance standard operating procedures across Khiron's plant-to-patient value chain based on the DEA protocols used to enforce compliance for the handling and distribution of controlled substances in the U.S.

Green Growth Brands, Inc. announced the opening of  its newest Seventh Sense Botanical Therapy CBD shop today at Mayfair Mall in Greater Milwaukee, a Brookfield Properties center. This new location represents the sixth Seventh Sense Shop to open in the United States.

"Mayfair Mall is the premier mall in Greater Milwaukee and we look forward to bringing a remarkable CBD store experience to new customers in the region," said Peter Horvath, CEO of Green Growth Brands. "Physical shops are our strongest marketing assets, and our presence in the new location will drive hundreds-of-thousands impressions with consumers. As we gear-up to open over 100 CBD shops by mid-summer we are pleased with early signs of conversion, repeat purchases and building engagement with our current shops and online with ShopSeventhSense.com."



Nextleaf Solutions Ltd. announced that it has been issued a patent by the United States Patent and Trade Office pertaining to the Company's proprietary process of extraction, refinement, and distillation of cannabinoids from marijuana and hemp.

The resulting THC or CBD distillate is tasteless, odourless, standardized for potency, and ready to use in a wide range of products, including topicals, transdermal or sublingual delivery technology, vape technology, edible oils, beverages, and water-soluble extracts. Nextleaf's patented technology allows for low-quality dried cannabis biomass to be efficiently processed into a high-purity distilled oil, simplifying the manufacturing of differentiated cannabinoid formulations and delivery methods.

Nextleaf further announced that it has been issued a standard patent by IP Australia – the Australian Government agency that administers intellectual property ("IP") rights - for the Company's unique, industrial-scale process of producing purified cannabinoid distillate.
The Company's management believes, to the best of its knowledge, that Nextleaf is the first publicly traded company to be issued a patent for the extraction and purification of cannabinoids.

"Nextleaf Solutions has succeeded in beating big pharma, big tobacco, big alcohol, and every single billion-dollar cannabis company to the first issued patent for the extraction and purification of cannabinoids." said Paul Pedersen, CEO. "We believe companies that can develop and protect valuable intellectual property will benefit substantially in the long-term, especially in an industry as young as the cannabis industry.”

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move.  Learn more https://www.investorideas.com/membership/





About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Learn more about Investor ideas podcast and news publication  services and costs https://www.investorideas.com/News-Upload/ 
Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411